- Home
- ENVB vs AYRO Comparison
ENVB vs AYRO Comparison
Compare ENVB & AYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVB
- AYRO
- Stock Information
- Founded
- ENVB 1994
- AYRO 2017
- Country
- ENVB United States
- AYRO United States
- Employees
- ENVB N/A
- AYRO N/A
- Industry
- ENVB Biotechnology: Pharmaceutical Preparations
- AYRO Telecommunications Equipment
- Sector
- ENVB Health Care
- AYRO Consumer Discretionary
- Exchange
- ENVB Nasdaq
- AYRO Nasdaq
- Market Cap
- ENVB 3.1M
- AYRO 3.7M
- IPO Year
- ENVB N/A
- AYRO N/A
- Fundamental
- Price
- ENVB $1.15
- AYRO $7.17
- Analyst Decision
- ENVB Strong Buy
- AYRO
- Analyst Count
- ENVB 1
- AYRO 0
- Target Price
- ENVB $10.00
- AYRO N/A
- AVG Volume (30 Days)
- ENVB 179.6K
- AYRO 38.5K
- Earning Date
- ENVB 08-11-2025
- AYRO 08-14-2025
- Dividend Yield
- ENVB N/A
- AYRO N/A
- EPS Growth
- ENVB N/A
- AYRO N/A
- EPS
- ENVB N/A
- AYRO N/A
- Revenue
- ENVB N/A
- AYRO $5,426.00
- Revenue This Year
- ENVB N/A
- AYRO N/A
- Revenue Next Year
- ENVB N/A
- AYRO N/A
- P/E Ratio
- ENVB N/A
- AYRO N/A
- Revenue Growth
- ENVB N/A
- AYRO N/A
- 52 Week Low
- ENVB $1.01
- AYRO $5.17
- 52 Week High
- ENVB $8.95
- AYRO $15.28
- Technical
- Relative Strength Index (RSI)
- ENVB 35.60
- AYRO 51.26
- Support Level
- ENVB $1.18
- AYRO $6.90
- Resistance Level
- ENVB $1.26
- AYRO $7.85
- Average True Range (ATR)
- ENVB 0.08
- AYRO 0.53
- MACD
- ENVB -0.02
- AYRO 0.07
- Stochastic Oscillator
- ENVB 3.10
- AYRO 49.43
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
About AYRO AYRO Inc.
AYRO Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.